2021
DOI: 10.7759/cureus.15000
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the Efficacy of the Cartridge-Based Nucleic Amplification (CBNAAT)/Xpert Test and Histology of Genital Tissues in Diagnosing Female Genital Tuberculosis

Abstract: BackgroundDiagnosing female genital tuberculosis (FGTB) is very difficult by routine laboratory investigations. Collecting tissues from genital structures, especially from tubes for histology, is impossible. The cartridgebased nucleic amplification (CBNAAT)/Xpert RIF test is a new polymerase chain reaction (PCR)-based method that is quick and may diagnose FGTB from any tissue type; however, it should not be contaminated with blood. This study was conducted to compare the efficacy of CBNAAT and the histology of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Investigation named GeneXpert assay was considered as gold standard to diagnose of genital TB. 16,17 2.1. The following investigations were used as an instrument in our study BACTEC Culture: BACTEC culture was a radiometric culture and released carbon dioxide by bacteria was measured.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Investigation named GeneXpert assay was considered as gold standard to diagnose of genital TB. 16,17 2.1. The following investigations were used as an instrument in our study BACTEC Culture: BACTEC culture was a radiometric culture and released carbon dioxide by bacteria was measured.…”
Section: Methodsmentioning
confidence: 99%
“…GeneXpert System or GeneXpert assay is a cartridge based nucleic acid amplification test (CBNAAT): It uses heminested real time PCR to amplify and simultaneously detect Mycobacterium tuberculosis complex (MTBC) and resistance to rifampin (RIF) within 100 minitues. 17 Due to constraints of our study objectives, we had not collected data for drug resistance.…”
Section: Methodsmentioning
confidence: 99%